Publications

Adalimumab Decorated Nanoparticles Enhance Antibody Stability and Therapeutic Outcome in Epithelial Colitis Targeting

Read publication

STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity - Nature Materials

Read publication

Peptide ligands on the PEGylated nanoparticle surface and human serum composition are key factors for the interaction between immune cells and nanoparticles

Read publication

[89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer - European Journal of Nuclear Medicine and Molecular Imaging

Read publication

Immunogenicity and protection efficacy of a COVID-19 DNA vaccine encoding spike protein with D614G mutation and optimization of large-scale DNA vaccine production

Read publication

IL-6–targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell function

Read publication

KIR3DL1 and Tox identify clonally expanded encephalitogenic neuron-specific CD8+ T cells in autoimmune encephalitis

Read publication

We are here to help

Our company provides more than just a selection of products. We can guide you to make the right choice to meet your needs and ensure that our products answer your scientific questions.

Mailing Address

AffinityImmuno Inc
DRC Building
550 University Ave
Charlottetown, PE
C1A 4P3, Canada

Shipping Address

AffinityImmuno Inc
DRC Building
550 University Ave
Charlottetown, PE
C1A 4P3, Canada

Cart

Publications

AffinityImmuno Reveals Strong Preclinical Results

Mice infected with COVID-19 saw as much as an 81 percent reduction in viral load.

Intravitreal administration of adalimumab delays retinal degeneration in rd10 mice

Adalimumab Decorated Nanoparticles Enhance Antibody Stability and Therapeutic Outcome in Epithelial Colitis Targeting

STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity - Nature Materials

Peptide ligands on the PEGylated nanoparticle surface and human serum composition are key factors for the interaction between immune cells and nanoparticles

[89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer - European Journal of Nuclear Medicine and Molecular Imaging

Immunogenicity and protection efficacy of a COVID-19 DNA vaccine encoding spike protein with D614G mutation and optimization of large-scale DNA vaccine production

IL-6–targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell function

KIR3DL1 and Tox identify clonally expanded encephalitogenic neuron-specific CD8+ T cells in autoimmune encephalitis

We are here to help

Mailing Address

Shipping Address

AffinityImmuno Inc. is a provider of R&D support services for your biological drug research and discovery.

ABOUT

OUR PRODUCTS

NEWSLETTER SUBSCRIPTION

Premier supplier of reagents and services for biological drug research.

ABOUT

NEWSLETTER SUBSCRIPTION

OUR PRODUCTS

Cart

stay informed!